Hikma Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
08 Aug 23 | Sell€630,880 | Bassam Wael Kanaan | Individual | 25,000 | €25.24 | |
06 Jun 23 | Buy€31,707 | Douglas Hurt | Individual | 1,500 | €21.14 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
State or Government | 161,453 | 0.0728% |
Employee Share Scheme | 525,916 | 0.237% |
Individual Insiders | 5,305,067 | 2.39% |
General Public | 39,098,767 | 17.6% |
Private Companies | 60,672,664 | 27.3% |
Institutions | 116,121,392 | 52.3% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
60,000,000 | €1.4b | 0% | no data | |||
12,232,204 | €275.4m | -2.49% | 0.01% | |||
7,312,808 | €164.7m | 1.21% | no data | |||
4,670,688 | €105.2m | -0.15% | 0.4% | |||
3,650,083 | €82.2m | 0% | 0.19% | |||
3,514,163 | €79.1m | -12.2% | 0.04% | |||
3,183,169 | €71.7m | -0.17% | 0.02% | |||
2,921,465 | €65.8m | -4% | 0.01% | |||
2,865,608 | €64.5m | -0.65% | 0.01% | |||
2,616,557 | €58.9m | 0.38% | 0.01% | |||
2,592,353 | €58.4m | 25% | 0.03% | |||
2,426,011 | €54.6m | 16.9% | 0.08% | |||
2,386,510 | €53.7m | -2.86% | 0.04% | |||
2,338,876 | €52.7m | 1.84% | no data | |||
2,107,969 | €47.5m | 51.8% | 0.03% | |||
2,063,451 | €46.5m | -40.3% | 0.02% | |||
1,753,791 | €39.5m | 0% | 0.18% | |||
1,535,980 | €34.6m | 27.7% | 0.01% | |||
1,498,104 | €33.7m | 15.5% | 0.01% | |||
1,491,332 | €33.6m | -26.7% | 0.15% | |||
1,446,367 | €32.6m | -13.1% | no data | |||
1,392,222 | €31.3m | 3.01% | no data | |||
1,391,692 | €31.3m | 11.7% | 0.3% | |||
1,346,335 | €30.3m | -0.35% | 2.48% | |||
1,339,176 | €30.2m | 187% | 0.02% |